Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620649
Title:
Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal.
Authors:
Tikhonova, I.A.; Jones-Hughes, T.; Dunham, J.; Warren, F. C.; Robinson, S.; Stephens, Peter; Hoyle, M.
Citation:
Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal. 2018, 36 (4):507 Pharmacoeconomics
Publisher:
Springer
Journal:
PharmacoEconomics
Issue Date:
Apr-2018
URI:
http://hdl.handle.net/11287/620649
DOI:
10.1007/s40273-018-0635-4
PubMed ID:
29478115
Additional Links:
https://dx.doi.org/10.1007/s40273-018-0635-4
Type:
Letter
Language:
en
ISSN:
1179-2027
Appears in Collections:
Oncology; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorTikhonova, I.A.en
dc.contributor.authorJones-Hughes, T.en
dc.contributor.authorDunham, J.en
dc.contributor.authorWarren, F. C.en
dc.contributor.authorRobinson, S.en
dc.contributor.authorStephens, Peteren
dc.contributor.authorHoyle, M.en
dc.date.accessioned2018-03-22T11:35:06Z-
dc.date.available2018-03-22T11:35:06Z-
dc.date.issued2018-04-
dc.identifier.citationCorrection to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal. 2018, 36 (4):507 Pharmacoeconomicsen
dc.identifier.issn1179-2027-
dc.identifier.pmid29478115-
dc.identifier.doi10.1007/s40273-018-0635-4-
dc.identifier.urihttp://hdl.handle.net/11287/620649-
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urlhttps://dx.doi.org/10.1007/s40273-018-0635-4en
dc.rightsArchived with thanks to PharmacoEconomicsen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.en
dc.titleCorrection to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal.en
dc.typeLetteren
dc.identifier.journalPharmacoEconomicsen
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.